Status:
UNKNOWN
Electrical Patient Reported Outcome of Prostate Cancer RadioTherapy
Lead Sponsor:
Helsinki University Central Hospital
Conditions:
Prostate Cancer
Eligibility:
MALE
18-100 years
Brief Summary
This is an observational study where prostate cancer related PROMs (EPIC-26) is collected using two different methods (by paper questionnaires and electronically) and patient experience and preference...
Detailed Description
Prostate cancer patients that are treated with radiation therapy for local prostate cancer receive EPIC-26 before treatment and during follow-up. EPIC-26 is collected both traditionally using paper qu...
Eligibility Criteria
Inclusion
- cT1-4N0M0, gleason 6-10, PSA \< 100, WHO ≤ 2 prostate cancer eligible for radiation therapy
- willing to complete EPIC-26 questionnaires both in paper and electronically
- willing to consent for the study
Exclusion
- not able to complete EPIC-26 both in paper and electronically
Key Trial Info
Start Date :
December 9 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05187026
Start Date
December 9 2016
End Date
December 31 2022
Last Update
January 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsinki University Hospital
Helsinki, Uusimaa, Finland, 00029